Background Eight randomized trials have evaluated whether the prophylactic use of an implantable cardioverter-defibrillator (ICD) improves survival among patients who are at risk for sudden death due to left ventricular systolic dysfunction but who have not had a life-threatening ventricular arrhyth...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!